Clinical Trial Details
EORTC-30954
Back to Clinical Trials Database
Intermittent maximal androgen blockade in patients with metastatic prostate cancer : Feasibility study.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 21-Mar-1996 Date Step1 close: 23-Oct-1997 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 100 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
